Document is current
Any future updates will be listed below
-
Authors
Martin-Alonso, Carmen
Alamdari, Sarah
Samad, Tahoura S.
Yang, Kevin K. https://orcid.org/0000-0001-9045-6826
Bhatia, Sangeeta N. https://orcid.org/0000-0002-1293-2097
Amini, Ava P. https://orcid.org/0000-0002-8601-6040
-
Funding
Funding for this research was provided by:
"la Caixa" Foundation
Virginia and D.K. Ludwig Fund for Cancer Research
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 25 November 2025
First Online: 6 January 2026
Competing interests
: C.M.A. is an employee of Amplifyer Bio. S.N.B. reports compensation for consulting or board membership by Amplifyer Bio, Catalio Capital, Danaher, Earli Inc., Impilo Therapeutics, Matrisome Bio, Ochre Bio, Port Therapeutics, Ropirio Therapeutics, Satellite Bio, Sunbird Bio, Vertex Pharmaceuticals, and Xilio Therapeutics. All other authors declare no competing interests.
